On April 25, 2022 Theratechnologies Inc. ("Theratechnologies" or "the Company") (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the Company’s participation in Bloom Burton & Co.’s Healthcare Investor Conference 2022 (Press release, Theratechnologies, APR 25, 2022, View Source [SID1234612913]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Theratechnologies Presentation Details:

Date: Tuesday, May 3, 2022
Presentation Time: 1:30PM ET
Location: Metro Toronto Convention Centre, Track B

The conference which features 66 of Canada’s premier publicly-traded and venture-backed private companies together with the most promising pre-venture companies in the healthcare industry. Investors have the opportunity to obtain corporate updates from presenting companies and participate in Bloom Burton’s 1-on-1 meeting system with company management. Only registered attendees can participate in the event. Register HERE to attend the event.